Thrombophilia cost-effectiveness of therapy: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. {{Thrombophilia}} ==References== {{reflist..." |
update |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Thrombophilia}} | {{Thrombophilia}} | ||
{{CMG}} {{AE}} {{asiri}} | |||
==Thrombophilia cost-effectiveness of therapy== | |||
*It is important to determine which patients require [[Thrombophilia_screening|screening]] for thrombophilia, and subsequently which patients require [[Thrombophilia_medical_therapy|treatment]]. | |||
*Certain [[Thrombophilia_history_and_symptoms|clinical scenarios]] may warrant [[Thrombophilia_screening|thrombophilia screening]]. | |||
*Unnecessary thrombophilia screening can lead to increased costs. | |||
==References== | ==References== |
Revision as of 05:30, 16 July 2016
Thrombophilia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Thrombophilia cost-effectiveness of therapy On the Web |
American Roentgen Ray Society Images of Thrombophilia cost-effectiveness of therapy |
Risk calculators and risk factors for Thrombophilia cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Asiri Ediriwickrema, M.D., M.H.S. [2]
Thrombophilia cost-effectiveness of therapy
- It is important to determine which patients require screening for thrombophilia, and subsequently which patients require treatment.
- Certain clinical scenarios may warrant thrombophilia screening.
- Unnecessary thrombophilia screening can lead to increased costs.